Mazzucato, Mariana;
Li, Henry Lishi;
(2020)
A market-shaping approach for the biopharmaceutical industry: governing innovation towards the public interest.
(Working Paper Series: IIPP WP
2020-21).
UCL Institute for Innovation and Public Purpose: London, UK.
Text
Mazzucato_final_iipp-wp2020-21_0.pdf - Published Version Download (522kB) |
Abstract
Enhancing research and development, and ensuring equitable pricing and access to cuttingedge treatments, are both vital to a biopharmaceutical innovation system that works in the public interest. However, despite delivering numerous therapeutic advances, the existing system suffers from major problems: a lack of directionality to meet key needs; inefficient collaboration; high prices that fail to reflect the public contribution; and an overly financialised business model. COVID-19 has magnified and focalized these challenges. We review these problems and argue that overcoming them requires a fundamental reframing of the role of the state in innovation, from market-fixing to market co-creation and co-shaping, in which risks and rewards are shared across a symbiotic public-private relationship.
Type: | Working / discussion paper |
---|---|
Title: | A market-shaping approach for the biopharmaceutical industry: governing innovation towards the public interest |
Open access status: | An open access version is available from UCL Discovery |
Publisher version: | https://www.ucl.ac.uk/bartlett/public-purpose/publ... |
Language: | English |
Additional information: | This version is the version of record. For information on re-use, please refer to the publisher’s terms and conditions. |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > UCL BEAMS UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of the Built Environment UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of the Built Environment > Inst for Innovation and Public Purpose |
URI: | https://discovery.ucl.ac.uk/id/eprint/10196635 |
Archive Staff Only
View Item |